<DOC>
	<DOC>NCT00992472</DOC>
	<brief_summary>The purpose of this study is to compare prochlorperazine plasma concentrations produced after administration of the test formulation with those produced after administration of a marketed reference product.</brief_summary>
	<brief_title>Bioavailability of Prochlorperazine Suppositories, 25 mg</brief_title>
	<detailed_description />
	<mesh_term>Prochlorperazine</mesh_term>
	<criteria>Good health as determined by lack of clinically significant abnormalities in health assessment performed at screening Positive test results for HIV or Hepatitis B or C History of allergy or sensitivity to Prochlorperazine or related drugs</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>